We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Faster
|
|
Mobile-First Design
|
|
Secure
|
|
Taking front-line vascular assessment to the next level
|
|
Clinically Valuable |
|
|
|
Easy-to-Use
|
Fair Financial Return
- Supports reimbursement of CPT codes 93924, 93923 and 93922
- Only device to support Peripheral Vascular Assessment Protocol
- 1 in 3 aged 70+, or 50+ with diabetes or a history of smoking have PAD